CLBT
Cellebrite DI·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CLBT
Cellebrite Di Ltd.
A global leader in Digital Intelligence (DI) solutions for the public and private sectors
Information Technology Services
04/13/1999
11/06/2020
NASDAQ Stock Exchange
1,167
12-31
Common stock
94 Shlomo Shmelzer Road Petah Tikva 4970602, Israel
--
Cellebrite DI Ltd., a company registered in Israel and established on April 13, 1999. Cellebrite DI is a leading provider of a suite of DI solutions, including software and services that are delivered to customers for use in legal sanctions investigations. The company's approximately 7,000 clients are federal, state and local agencies, as well as enterprise companies and service providers. The company's suite of DI solutions allows clients to collect, review, analyze and manage digital data throughout the survey lifecycle. The company's suite of DI solutions extracts digital data, presents the data as digital evidence, and makes the evidence actionable.
Earnings Call
Company Financials
EPS
CLBT has released its 2025 Q3 earnings. EPS was reported at 0.14, versus the expected 0.13, beating expectations. The chart below visualizes how CLBT has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CLBT has released its 2025 Q3 earnings report, with revenue of 126.03M, reflecting a YoY change of 17.94%, and net profit of 20.19M, showing a YoY change of 109.75%. The Sankey diagram below clearly presents CLBT's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


